Search Results - "Algotar, A. M."

Comprehensive Lifestyle Improvement Program for Prostate Cancer (CLIPP) is associated with improvement in weight and components of metabolic syndrome in men exposed to androgen deprivation therapy for prostate cancer by Algotar, A. M., Hsu, C. H., Chow, H-H., Dougherty, S. T., Babiker, H. M., Marrero, D. G., Abraham, I., Kumar, R., Ligibel, J. A., Courneya, K. S., Smith, T. E., Jones, P. A., Lopez, J. N., Niemiro, G., Ramakumar, S., Hoy, R. D., Mack, C., Thomson, C. A.

“…Background Androgen deprivation therapy (ADT) for prostate cancer is associated with adverse effects, such as obesity and metabolic syndrome, which increase…”
Get full text

Dose-Dependent Effects of Selenized Yeast on Total Selenium Levels in Prostatic Tissue of Men With Prostate Cancer by Algotar, A. M., Stratton, M. S., Xu, M. J., Dalkin, B. L., Nagle, R. B., Hsu, C. H., Ahmann, F. R., Clark, L. C., Stratton, S. P.

Get full text

Protocol for a feasibility and early efficacy study of the Comprehensive Lifestyle Improvement Program for Prostate Cancer-2 (CLIPP2) by Algotar, A.M., Kumar, R., Babiker, H.M., Dougherty, S.T., Hsu, C.H., Chow, H.-H., Smith, T.E., Marrero, D.G., Courneya, K.S., Abraham, I., Ligibel, J.A., Thomson, C.A.

“…Although androgen deprivation therapy (ADT) for prostate cancer demonstrates improved overall and disease-free survival, it is associated with adverse effects…”
Get full text

Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity by Algotar, A. M., Thompson, P. A., Ranger-Moore, J., Stratton, M. S., Hsu, C. H., Ahmann, F. R., Nagle, R. B., Stratton, S. P.

“…Background:  Current diagnostic tools are inadequate for reliable prediction of prostate cancer (PCa) aggressiveness in patients with localised disease. This…”
Get full text

No Effect of Selenium Supplementation on Serum Glucose Levels in Men with Prostate Cancer by Algotar, Amit M., PhD, MBBS, Stratton, Mimi Suzanne, PhD, Stratton, Steven P., PhD, Hsu, Chiu-Hsieh, PhD, Ahmann, Frederick R., MD

“…Abstract Background Literature indicates a relationship between selenium supplementation and risk of diabetes. However, because these data are inconclusive, we…”
Get full text

Phase IIb clinical trial of selenium in prostate cancer patients on active surveillance by Stratton, M., Algotar, A. M., Ranger-Moore, J., Slate, E., Hsu, P., Stratton, S. P., Thompson, P. A., Ahmann, F. R.

“…Abstract only…”
Get full text

Oral selenium supplementation has no effect on PSA velocity in men undergoing active surveillance for localized prostate cancer by Stratton, M. S., Algotar, A. M., Ranger-Moore, J., Stratton, S. P., Slate, E., Hsu, C.H, Thompson, P.A., Clark, L. C., Ahmann, F. R.

Get full text

522-S: Results of a Survey to Assess Colorectal Cancer Screening Capacity in Arizona by Algotar, A M, Martinez, E M, McKnight, P E, Heigh, R I, Lance, P

Get full text